Veracyte | VCYT - Cost Of Sales

Stock Price
36.16
Daily Change
1.30 3.73%
Monthly
-19.84%
Yearly
-12.99%
Q1 Forecast
36.91

Veracyte reported $41.21M in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Agilent USD 871M 28M Sep/2025
Bruker USD 481.1M 41.6M Sep/2025
Exact Sciences USD 266.81M 18.18M Sep/2025
Illumina USD 400M 49M Dec/2025
Laboratory Of America USD 2.54B 11M Sep/2025
Ligand Pharmaceuticals USD 11.9M 733K Sep/2025
Myriad Genetics USD 61.9M 600K Sep/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
Siemens EUR 13.32B 1.48B Sep/2025
Sonic Healthcare AUD 751.66M 801.13M Dec/2024
Thermo Fisher Scientific USD 7.58B 674M Dec/2025
Veracyte USD 41.21M 196K Sep/2025
Waters USD 327.81M 5.5M Sep/2025